AccentureLifeScience

@AccentureLifSci

Accenture Life Sciences helps pharma, biotech, med-tech, distribution and consumer health sectors rethink, reshape & restructure for better patient outcomes.

Global
Vrijeme pridruživanja: lipanj 2011.

Tweetovi

Blokirali ste korisnika/cu @AccentureLifSci

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AccentureLifSci

  1. Prikvačeni tweet
    27. sij

    Calling global & life sciences ! Apply now for Accenture Life Sciences

    Poništi
  2. 4. velj

    40% of companies have not deployed digital in the lab. Our new report maps out the journey to turn oceans of siloed information into innovative therapies:

    Poništi
  3. proslijedio/la je Tweet
    27. sij

    We’re proud to achieve SAP Model Company certifications for faster implementation & time-to-value with industry solutions:

    Poništi
  4. 31. sij

    Who will manage and capitalize on the tsunami of CGT development assets? We see 6 types of emerging businesses.

    Poništi
  5. 30. sij

    Attention ! Our life sciences is accepting applications thru February 29, 2020.

    Poništi
  6. 30. sij

    With a cloud-based platform at the heart of its business, Merck KGaA is improving fulfillment to ensure patients have the medicine they need:

    Poništi
  7. 29. sij

    We are working with Biopharma Chief Scientific Officers and Research & Development leaders to fix productivity issues and develop new drugs radically faster and more effectively. Find out more:

    Poništi
  8. 29. sij

    Be a leader in the digital world—and improve the lives of people everywhere—with these 5 key enablers:

    Poništi
  9. 27. sij

    New Science will account for 54% of sales by 2022. Is your lab ready for the latest wave of R&D technology?

    Poništi
  10. 27. sij

    See how Merck KGaA’s new digital backbone—a more agile and nimble ERP platform—is helping them get medicine to patients faster:

    Poništi
  11. 23. sij

    How can cancer care teams make better treatment decisions faster? Learn how Roche’s NAVIFY® Tumor Board digital data integration solution is transforming prep for tumor board meetings.

    Poništi
  12. 22. sij

    6 out of ten marketing execs say their marketing organization isn’t ready for Artificial Intelligence. See how to make AI happen now. Learn more.

    Poništi
  13. 21. sij

    How can life sciences companies apply truly innovative clinical operations that consist of a cross-section of talented people, with the right clinical data science skills embedded into a well-functioning clinical governance model?

    Poništi
  14. 20. sij

    Are you ready to unlearn and relearn the value chain to bring transformative therapies to patients? Learn more:

    Poništi
  15. 20. sij

    Most CEOs say they have the right IT systems, but are failing to get full value from them. Why? We'll share more next week at :

    Poništi
  16. 17. sij

    Four days. 1,500 leaders. One mission to drive positive change and improve the state of the world.

    Poništi
  17. 16. sij

    Over half of marketing execs (57%) have access to data but are struggling to make better decisions with it. It’s time to change the dynamic. Learn more.

    Poništi
  18. 14. sij

    Accenture congratulates Dr. Sandra Horning , as HBA’s Woman of the Year and is proud to host this year’s meeting. It's exciting to see orgs such as HBA supporting companies that recognize the power of the diversity.

    Poništi
  19. 14. sij

    Find out how Roche’s data platform NAVIFY® Tumor Board is helping specialists spend less time preparing for meetings—and more time discussing patients.

    Poništi
  20. 8. sij

    Cancer care teams need patient information from many sources to make the best decisions. Find out how Roche’s NAVIFY® Tumor Board is helping tumor boards do it faster and better.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·